Cannabis clinical trials at UCLA
6 in progress, 4 open to eligible people
Age-dependent Effects of Smoked and Oral Delta-9-THC
open to eligible people ages 18-65
This study will assess the age-dependent effects of smoked and oral THC on abuse liability, intoxication, analgesia and impairment as a function of age.
Los Angeles 5368361, California 5332921
Cannabis Effects as a Function of Sex
open to eligible people ages 21-55
The purpose of this research is to assess the impact of cannabis on the analgesic and abuse-related effects between men and women
Los Angeles 5368361, California 5332921
Smoked THC and CBD in Men and Women
open to eligible people ages 21-55
The purpose of this study is to determine the pharmacokinetics and pharmacodynamics of inhaled cannabis with varying amounts of delta-9-tetrahydrocannabinol (THC), and cannabidiol (CBD) and to evaluate detection of recently smoked THC in oral fluid.
Los Angeles 5368361, California 5332921
High Potency Cannabis: Acute and Protracted Effects
open to eligible people ages 21-55
The purpose of this research is to assess the effects of smoked cananbis when cannabis is smoked during periods of cannabis use as usual and after a brief period of abstinence.
Los Angeles 5368361, California 5332921
Analgesic and Subjective Effects of Terpenes
Sorry, in progress, not accepting new patients
The purpose of this research is to assess the analgesic and subjective effects of terpenes administered alone and in combination of THC.
Los Angeles 5368361, California 5332921
THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy
Sorry, not yet accepting patients
The purpose of this research is to assess the impact of CBD on the effects of THC.
Our lead scientists for Cannabis research studies include Ziva Cooper, PhD.